Effects of lifestyle and glucagon-like Peptide-1 receptor agonist-based therapies on waist circumference: A systematic review and meta-analysis
S. Ghosal, A. Ghosal · 2026
Read Effects of lifestyle and glucagon-like Peptide-1 receptor agonist-based therapies on waist circumference: A systematic review and meta-analysis by S. Ghosal, A. Ghosal (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13272577.txt.
Description
S. Ghosal and A. Ghosal pooled trials on waist size in a 2026 systematic review and meta-analysis. A large waist signals belly fat and higher risk for heart and metabolic disease. The review compared lifestyle steps and newer weight loss drugs based on GLP-1, a gut hormone.
The team gathered 21 randomized trials with 3,196 adults, covering diet, exercise, combined programs, and GLP-1 based drugs. On average, treatment cut waist size by more than four centimeters compared with control groups. The drug based therapies and diet alone showed the clearest cuts. Exercise results varied more. Waist change also tracked change in deep belly fat. The authors note possible bias from small studies, so results need care.
Catalog record
| CREATOR | S. Ghosal, A. Ghosal |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |